PreveCeutical Medical Inc.
PRVCF
Rank in Stocks
#29054
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating... PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Share Price
$0.0123
Last synced: 2026-11-09
Market Cap
$9.04M
Change (1 day)
-20.65%
Change (1 year)
-22.54%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PreveCeutical Medical Inc. (PRVCF)
Category
Healthcare
EPS for PreveCeutical Medical Inc. (PRVCF)
EPS as of June 2026 TTM: $0.00
According to PreveCeutical Medical Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for PreveCeutical Medical Inc. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 33.33% |
| 2025 | 0.00 | 33.33% |
| 2024 | 0.00 | -16.67% |
| 2023 | 0.00 | -14.29% |
| 2022 | 0.00 | -22.22% |
| 2021 | 0.00 | -58.46% |
| 2020 | $-0.01 | -5.80% |
| 2019 | $-0.01 | -74.91% |
| 2018 | $-0.03 | 7.00% |
| 2017 | $-0.03 | 110.66% |
| 2016 | $-0.01 | 293.55% |
| 2015 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,957,600.00% |
US
|
|
| $-7.07 | 883,650.00% |
US
|
|
| $-5.29 | 661,150.00% |
AU
|
|
| $12.88 | -1,610,112.50% |
BE
|
|
| $21.56 | -2,695,100.00% |
NL
|
Questions about PreveCeutical Medical Inc.'s earnings per share (EPS)
What is PreveCeutical Medical Inc.'s earnings per share (EPS)?
PreveCeutical Medical Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was PreveCeutical Medical Inc.'s earnings per share (EPS) in 2025?
In 2025, PreveCeutical Medical Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has PreveCeutical Medical Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, PreveCeutical Medical Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2020 ($-0.01).
How does PreveCeutical Medical Inc.'s earnings per share (EPS) compare with similar companies?
PreveCeutical Medical Inc.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.